AC

Ayer Capital Management

North America, California, United States, San Francisco

Description

Ayer Capital Management, LP and its managed funds are not open for investment by members of the public.

Investor Profile

Ayer Capital Management has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Ayer Capital Management frequently co-invest with?

DC
North America, Illinois, United States, Deerfield
Co-Investments: 1
Iroquois Capital
North America, Tennessee, United States, Nashville
Co-Investments: 1
Hartz Mountain Industries
North America, New Jersey, United States, Secaucus
Co-Investments: 1
Dafna Capital Management
North America, California, United States, Los Angeles
Co-Investments: 1
Heights Capital Management
North America, California, United States, San Francisco
Co-Investments: 1
ArmaVir Partners
North America, New York, United States, New York
Co-Investments: 1
Cowen Group
North America, New York, United States, New York
Co-Investments: 1
KP
North America, New York, United States, New York
Co-Investments: 1
SP
Europe, Midtjylland, Denmark, Holstebro
Co-Investments: 1

What are some of recent deals done by Ayer Capital Management?

Cascadian Therapeutics

Seattle, Washington, United States

Cascadian Therapeutics is a bio-pharmaceutical company that researches, develops, and sells therapeutic products for treatment of cancer.

BiotechnologyHealth CareTherapeutics
Post Ipo EquitySep 24, 2010
Amount Raised: $14,900,000